EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Evaluation of a novel biplex rapid diagnostic test for antibody responses to Loa loa and Onchocerca volvulus infections

Jérémy T Campillo iD, Marco A Biamonte, Marlhand C Hemilembolo, François Missamou, Michel Boussinesq, Sébastien D S Pion, Cédric B Chesnais

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0012567 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Jérémy T Campillo und 6 weiteren Autor:innen. Beteiligte Einrichtung: UMI 233 TransVIHMI, Université Montpellier, Institut de Recherche pour le Développement (IRD), INSERM Unité 1175, Montpellier, France. Hauptthemen laut MEDLINE: Loiasis, Loa, Onchocerca volvulus, Onchocerciasis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HORIZON EUROPE European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Endemic to Central Africa, loiasis, caused by the vector-borne worm Loa loa , affects approximately 10 million individuals. Clinical manifestations include transient angioedema (Calabar swellings), migration of the adult worm under the eye conjunctiva (eye worm) and less specific general symptoms. Loiasis presents a significant public health challenge because L . loa -infected individuals can develop serious adverse events after taking ivermectin, the drug used to combat onchocerciasis. In this context, alternative interventions and rigorous diagnostic approaches are needed. Diagnosing loiasis is challenging because its main clinical manifestations are sporadic and non-specific. The definitive diagnosis relies on identifying adult worms migrating beneath the conjunctiva, or microfilariae (pre-larvae) in blood smears. However, “occult loiasis” (infection without blood microfilariae) is frequent. Serological rapid antibody diagnostic tests (ARTs) can provide an alternative diagnostic method. We compared a novel ART simultaneously targeting onchocerciasis (IgG4 to Ov-16 and OvOC3261, test line 1) and loiasis (IgG4 to L1-SXP-1, test line 2), called IgG4-SXP-1 biplex test) to the already established Loa -ART (all IgG isotypes to Ll-SXP-1, called pan-IgG-SXP-1 test). Methodology Blood samples underwent both ARTs, read qualitatively and semi-quantitatively. Additionally, blood smears, skin snips, Kato-Katz method for soil-transmitted helminthiases identification and eosinophilia measurements were performed. Questionnaires gathered demographic details and loiasis-related signs. ARTs performance was compared using specific loiasis-related signs and microfilaremia as references. Discordances between the two ARTs were investigated using logistic regression models. Principal findings Out of 971 participants, 35.4% had L . loa microfilaremia, 71.9% had already experienced loiasis-related signs, 85.1% were positive in the pan-IgG-SXP-1 test and 79.4% were positive in the IgG4-SXP-1 biplex test. In the microfilariae-positive population, the sensitivity of the rapid tests was 87.4% for the pan-IgG-SXP-1 test and 88.6% for the prototype IgG4-SXP-1 biplex test. Sensitivity was similar for both ARTs when using eye worm or Calabar swelling as references, but diagnostic performance varied based on microfilaremia levels and occult loiasis. Overall, IgG4-SXP-1 biplex test demonstrated a sensitivity of 84.1% and specificity of 47.6% for loiasis compared to the pan-IgG-SXP-1 test, leading to a Kappa coefficient estimated at 0.27 ± 0.03 for the qualitative results of the 2 ARTs. In the group that tested positive with the Pan-IgG test but negative with the IgG4-specific test, there was a lower prevalence of STH infection (p = 0.008) and elevated eosinophilia (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LoiasisLoaOnchocerca volvulusOnchocerciasisAntibodies, HelminthSensitivity and SpecificityAnimalsHumansFemaleAdultMaleMiddle AgedYoung AdultAdolescentChildAgedImmunoglobulin GDiagnostic Tests, RoutineRapid Diagnostic Tests

Substanzen

Antibodies, HelminthImmunoglobulin G

Autor:innen und Institutionen

  • UMI 233 TransVIHMI, Université Montpellier, Institut de Recherche pour le Développement (IRD), INSERM Unité 1175, Montpellier, France.
  • Drugs & Diagnostics for Tropical Diseases, San Diego, California, United States of America.
  • Programme National de Lutte contre l'Onchocercose, Direction de l'Épidémiologie et de la Lutte contre la Maladie, Ministère de la Santé et de la Population, Brazzaville, Republic of the Congo.

ORCID-Profile: Jérémy T Campillo

Förderung

  • NIAID NIH HHS
  • HORIZON EUROPE European Research Council

Zitieren

APA

Campillo, J. T., Biamonte, M. A., Hemilembolo, M. C., Missamou, F., Boussinesq, M., Pion, S. D. S., & Chesnais, C. B. (2024). Evaluation of a novel biplex rapid diagnostic test for antibody responses to Loa loa and Onchocerca volvulus infections. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012567

Vancouver

Campillo JT, Biamonte MA, Hemilembolo MC, Missamou F, Boussinesq M, Pion SDS, et al. Evaluation of a novel biplex rapid diagnostic test for antibody responses to Loa loa and Onchocerca volvulus infections. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012567

BibTeX
@article{Campillo2024,
  author = {Campillo, Jérémy T and Biamonte, Marco A and Hemilembolo, Marlhand C and Missamou, François and Boussinesq, Michel and Pion, Sébastien D S and Chesnais, Cédric B},
  title = {Evaluation of a novel biplex rapid diagnostic test for antibody responses to Loa loa and Onchocerca volvulus infections},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0012567}
}
Kostenlos starten →